ArticleBreast cancer research and treatment2025

BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors.

Kavitha Däster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.